PRME Q2 2025 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena

PRMEPrime Medicine, Inc.

$771M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

-$749,000-67.2% margin

Operating Income

-$53M-4787.2% margin

Net Income

-$53M-4716.7% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

-23.3%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$43M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$279M

Total Liabilities

$218M

Stockholders' Equity

$61M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	-$749,000	$0	—
Operating Income	-$53M	-$56M	+4.1%
Net Income	-$53M	-$55M	+4.9%

Revenue Segments

Reportable Segment

$1M100%